Back to Peptide Encyclopedia
Cognitive EnhancementStrong Evidence
Semax
Neuropeptide approved in Russia, derived from ACTH(4-10), with neuroprotective activity.
Prescription3 protocols
Approved by select regulatory agencies — not FDA/EMA
·Educational information. Not medical advice or a recommendation for use.Key Facts: Semax
Category
Cognitive Enhancement
Evidence
Strong Evidence
Availability
Prescription
Protocols
3
Research Overview & Mechanisms
Enhances BDNF, modulates neurotrophins and dopaminergic signaling.
Reported Research Benefits
Cognitive enhancement
Neuroprotection
BDNF
Available Protocols
Frequently Asked Questions
FAQ
Neuropeptide approved in Russia, derived from ACTH(4-10), with neuroprotective activity.
Advanced Compound Intelligence
—
Human studies
—
Key studies
1
Interactions
Strong Evidence
Evidence tier
Verified intelligence
Research summaryClinical Evidence
Strong Evidence
View all studies on PubMedSupported by multiple randomized controlled trials and systematic reviews.
Known Interactions
Synergistic
Scientific Sources & Further Reading
Explore peer-reviewed research about Semax:
External links open in new tabs. Always verify information with qualified healthcare providers.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →